Related Documents
Information Leaflets
Disease Modifying Drugs in Inflammatory Bowel Disease (IBD)
The following documents are designed to provide information for Gastroenterologists and Primary Care Clinicians regarding the use of disease modifying drugs, their indications, side effects and guidelines for safe monitoring. This document does not cover the use of biological agents whose use is considered elsewhere.
- Azathioprine [ 40kb ]
- Ciclosporin [ 38kb ]
- Methotrexate [ 53kb ]
- Aminosalicylates (5-ASA) [ 40kb ]
For patient information please click here
NHS Do Once and Share Project - Inflammatory Bowel Disease:
- Requirements for an Electronic Care Record for IBD patients
- Notes and References [ 60 kb ]
Algorithm for evaluating TB prior to anti-TNF therapy
- Notes and References [ 26 kb ]
Related Organisations
Inflammatory Bowel Disease Research Grants - Broad Medical Research Program, USA
- Brochure [ 1.9 Mb ]
 Disease Modifying Drugs in Inflammatory Bowel Disease (IBD) | [All documentation (Cons Gastro & patient information)] | 206 Kb |